Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

@inproceedings{Linden2015TreatmentsAC,
  title={Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands},
  author={Naomi van der Linden and Jan Buter and Chris P. Pescott and Roy I. Lalisang and Jan-Paul de Boer and Alexander de Graeff and Carla M. L. van Herpen and Robert J Baatenburg de jong and Carin A. Uyl-de Groot},
  booktitle={European Archives of Oto-Rhino-Laryngology},
  year={2015}
}
For patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), chemotherapy can prolong life and alleviate symptoms. However, expected gains may be small, not necessarily outweighing considerable toxicity and high costs. Treatment choice is to a large extent dependent on preferences of doctors and patients and data on these choices are scarce. The purpose of this study is to obtain real-world information on palliative systemic treatment and costs of R/M… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Dispelling the myths around cancer care delivery: it’s not all about costs

  • CA Uyl-deGroot, EGE de Vries, J Verweij, R Sullivan
  • J Cancer Policy
  • 2014
1 Excerpt

Pathology of head and neck neoplasms

  • G Haines
  • UpToDate
  • 2013
1 Excerpt

Treatment of metastatic and recurrent head and neck cancer

  • B Brockstein, E Vokes
  • Basow D (ed) UpToDate. UpToDate,
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…